Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles

被引:108
作者
Duceppe, Nicolas [2 ,3 ]
Tabrizian, Maryam [1 ,2 ,3 ,4 ]
机构
[1] Fac Dent, Montreal, PQ H3A 2B2, Canada
[2] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Ctr Biorecognit & Biosensors, Montreal, PQ H3A 2B4, Canada
[4] McGill Inst Adv Mat, Montreal, PQ H3A 2A7, Canada
关键词
Ultra low molecular weight chitosan; Hyaluronic acid; Nanoparticles; Gene delivery; Non-viral vector; Nanocarrier; GENE DELIVERY; BIOLOGICAL-ACTIVITIES; CHITOSAN POLYPLEXES; DNA; CD44; THERAPY; SYSTEMS; CELLS;
D O I
10.1016/j.biomaterials.2009.01.017
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
The present work describes nanoparticles made of ultra low molecular weight chitosan (ULMWCh)/hyaluronic acid (HA) as novel potential carriers for gene delivery. Small and monodispersed nanoparticles with high in vitro transfection capabilities have been obtained by the complexation of these two polyelectrolytes. ULMWCh (<10 kDa) presents more advantageous characteristics over the higher molecular weight chitosan for clinical applications, namely increased solubility at physiological pH and improved DNA release. The ULMWCh:HA ratio and the HA molecular weights were varied with the aim of obtaining particles in the 100 nm range. Using chitosan (Ch) with a molecular weight of 5 kDa, HA with a molecular weight of 64 kDa, and a weight ratio of 4:1, nanoparticles with a Z-average size of 146 +/- 1 nm and narrow size distribution (polydispersity index: 0.073 +/- 0.030) were obtained. Nanoparticle images taken in dry conditions by SEM and AFM showed spherical particles. The optimal pH for transfection ranged from 6.4 to 6.8 for 0.25 mu g of EGFP plasmid per well, with an incubation time of 4 h. Using these optimized parameters, DNA/ULMWCh:HA nanoparticles successfully transfected 25 + 1% of the 293T cells with pEGFP, compared to 0.7% obtained for DNA/ULMWCh under the same conditions. This high transfection efficiency of our non-viral gene delivery system could be attributed to the synergic effect of ULMWCh and low charge density of the HA chain for easy release of DNA which makes the system suitable for targeted gene delivery. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2625 / 2631
页数:7
相关论文
共 40 条
[1]
Hyaluronan [J].
Almond, A. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (13) :1591-1596
[2]
CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[3]
Preparation of chitosan particles suitable for enzyme immobilization [J].
Biro, Emese ;
Nemeth, Agnes Sz. ;
Sisak, Csaba ;
Feczko, Tivadar ;
Gyenis, Janos .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2008, 70 (06) :1240-1246
[4]
Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J].
Corsi, K ;
Chellat, F ;
Yahia, L ;
Fernandes, JC .
BIOMATERIALS, 2003, 24 (07) :1255-1264
[5]
Glycosaminoglycan destabilization of DNA-chitosan polyplexes for gene delivery depends on chitosan chain length and GAG properties [J].
Danielsen, S ;
Strand, S ;
Davies, CD ;
Stokke, BT .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1721 (1-3) :44-54
[6]
Design of novel polysaccharidic nanostructures for gene delivery [J].
de la Fuente, M. ;
Seijo, B. ;
Alonso, M. J. .
NANOTECHNOLOGY, 2008, 19 (07)
[7]
Design of modular non-viral gene therapy vectors [J].
De Laporte, L ;
Rea, JC ;
Shea, LD .
BIOMATERIALS, 2006, 27 (07) :947-954
[8]
Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors [J].
Douglas, Kimberly L. ;
Piccirillo, Ciriaco A. ;
Tabrizian, Maryam .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (03) :676-687
[9]
Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles [J].
Douglas, Kimberly L. ;
Piecirillo, Ciriaco A. ;
Tabrizian, Maryam .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (03) :354-361
[10]
What do we (need to) know about the kinetic properties of nanoparticles in the body? [J].
Hagens, Werner I. ;
Oomen, Agnes G. ;
de Jong, Wim H. ;
Cassee, Flemming R. ;
Sips, Adrienne J. A. M. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2007, 49 (03) :217-229